Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Tech Transfer Awards
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • NIH IRP Access Planning Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

"Stable End-Point" Microculture Tetrazolium Assay (SE-MTA)

  • Read more about "Stable End-Point" Microculture Tetrazolium Assay (SE-MTA)
Patent Cooperation Treaty
PCT/US1992/003885
Filed on 1992-05-18

Method for Designing Cancer Treatment Regimens and Methods and Pharmaceutical Compositions for the Treatment of Cancer

  • Read more about Method for Designing Cancer Treatment Regimens and Methods and Pharmaceutical Compositions for the Treatment of Cancer
Patent Cooperation Treaty
PCT/US1992/003830
Filed on 1992-05-08

MICHELLAMINES USEFUL AS ANTIVIRAL AGENTS, COMPOSITION AND METHOD OF TREATMENT

  • Read more about MICHELLAMINES USEFUL AS ANTIVIRAL AGENTS, COMPOSITION AND METHOD OF TREATMENT
Patent Cooperation Treaty
PCT/US1992/002805
Filed on 1992-04-10

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PREVENTING SKIN TUMOR FORMATION AND CAUSING REGRESSION OF EXISTING TUMORS

  • Read more about PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PREVENTING SKIN TUMOR FORMATION AND CAUSING REGRESSION OF EXISTING TUMORS
Patent Cooperation Treaty
PCT/US1992/002564
Filed on 1992-03-30

THE TRK TYROSINE KINASE RECEPTOR IS THE PHYSIOLOGICAL RECEPTOR FOR NERVE GROWTH FACTOR

  • Read more about THE TRK TYROSINE KINASE RECEPTOR IS THE PHYSIOLOGICAL RECEPTOR FOR NERVE GROWTH FACTOR
Patent Cooperation Treaty
PCT/US1992/002112
Filed on 1992-03-16

Hepatic Growth Factor Receptor is the Met Proto-Oncogene

  • Read more about Hepatic Growth Factor Receptor is the Met Proto-Oncogene
Patent Cooperation Treaty
PCT/US1992/000071
Filed on 1992-01-15

IMMORTALIZED HUMAN CELL LINES

  • Read more about IMMORTALIZED HUMAN CELL LINES
Patent Cooperation Treaty
PCT/US1992/000015
Filed on 1992-01-02

SUSTAINED AND CONTINUOUS PRODUCTION OF HIGH TITERS OF RECOMBINANT VIRAL VECTORS AND TRANSDUCED TARGET CELLS FOR USE IN GENE THERAPY

  • Read more about SUSTAINED AND CONTINUOUS PRODUCTION OF HIGH TITERS OF RECOMBINANT VIRAL VECTORS AND TRANSDUCED TARGET CELLS FOR USE IN GENE THERAPY
Patent Cooperation Treaty
PCT/US1991/009069
Filed on 1991-12-10

RECOMBINANT IMMUNOTOXIN COMPOSED OF A SINGLE CHAIN ANTIBODY REACTING WITH THE HUMAN TRANSFERRIN RECEPTOR AND DIPHTHERIA TOXIN

  • Read more about RECOMBINANT IMMUNOTOXIN COMPOSED OF A SINGLE CHAIN ANTIBODY REACTING WITH THE HUMAN TRANSFERRIN RECEPTOR AND DIPHTHERIA TOXIN
Patent Cooperation Treaty
PCT/US1991/008819
Filed on 1991-12-03

CELL STRESS TRANSCRIPTIONAL FACTORS

  • Read more about CELL STRESS TRANSCRIPTIONAL FACTORS
Patent Cooperation Treaty
PCT/US1991/008592
Filed on 1991-11-22

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1499
  • Page 1500
  • Page 1501
  • Page 1502
  • Page 1503
  • Page 1504
  • Page 1505
  • Page 1506
  • Page 1507
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health